Chemours (CC) Non-Current Deffered Revenue (2015 - 2021)

Chemours' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $2.0 million for Q4 2021.

• On a quarterly basis, Non-Current Deffered Revenue fell 60.0% year-over-year to $2.0 million in Q4 2021; TTM through Dec 2021 was $2.0 million, a 60.0% decrease from a year earlier, with the FY2021 full-year figure at $2.0 million, down 60.0% from the prior year.
• Non-Current Deffered Revenue fell to $2.0 million in Q4 2021 per CC's latest filing, from $5.0 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $8.0 million in Q3 2018 and bottomed at $2.0 million in Q4 2021.
• The 5-year median for Non-Current Deffered Revenue is $5.0 million (2018), against an average of $5.5 million.
• Across the five-year window, Non-Current Deffered Revenue grew 20.0% in 2017 and sank 60.0% in 2021, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $6.0 million in 2017, then gained by 16.67% to $7.0 million in 2018, then rose by 14.29% to $8.0 million in 2019, then tumbled by 37.5% to $5.0 million in 2020, then sank by 60.0% to $2.0 million in 2021.
• Per Business Quant, the three latest CC Non-Current Deffered Revenue figures stand at $2.0 million (Q4 2021), $5.0 million (Q3 2021), and $5.0 million (Q2 2021).